PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights PART 05: Overview: Consumer healthcare market • OTC pharmaceuticals • Dietary supplements • Key buying criteria • Factors influencing go-to-market strategy PART 06: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 07: Market segmentation by consumer healthcare products • OTC pharmaceuticals • Dietary supplements PART 08: Geographical segmentation • Global consumer healthcare market by geographical segmentation 2016-2020 • Consumer healthcare market in Americas • Consumer healthcare market in APAC • Consumer healthcare market in EMEA PART 09: Key leading countries • US • China • Japan PART 10: Market drivers • Awareness about lifestyle diseases • Increase in self-medication • Growing older population • Rise in disposable income • Increase in switch from prescription to OTC products PART 11: Impact of drivers PART 12: Market challenges • Intense competition • Lack of valid literature • Adverse effects • Counterfeit pharmaceuticals • Stringent regulations and guidelines PART 13: Impact of drivers and challenges PART 14: Market trends • Accelerated use of online resources • New product launches • Promotions and marketing initiatives • Strategic alliances PART 15: Vendor landscape • Competitive scenario • Market share 2015 PART 16: Key vendor analysis • Johnson & Johnson • Bayer HealthCare • GlaxoSmithKline • Sanofi • Pfizer • Boehringer Ingelheim • Other prominent vendors PART 17: Appendix • List of abbreviations PART 18: Explore Technavio List of Exhibits Exhibit 01: Product offerings Exhibit 02: Types of consumer healthcare products Exhibit 03: Key regulatory bodies that approve OTC products Exhibit 04: FDA OTC drug approval process Exhibit 05: Mechanisms to amend OTC drug monograph Exhibit 06: Comparison of OTC NDA versus OTC monograph process Exhibit 07: Strategies to establish OTC pharmaceuticals in emerging markets Exhibit 08: Recommendation of dietary supplements by health professionals Exhibit 09: Key buying criteria in global consumer healthcare market Exhibit 10: Factors that influence the go-to-market strategy in global consumer healthcare market Exhibit 11: Global consumer healthcare market 2015-2020 ($ billions) Exhibit 12: Five forces analysis Exhibit 13: Segmentation of global consumer healthcare market by products Exhibit 14: Global OTC pharmaceuticals market 2015-2020 ($ billions) Exhibit 15: Global OTC pharmaceuticals market by geography 2015 Exhibit 16: Segmentation of global OTC pharmaceuticals by therapeutic class Exhibit 17: Global OTC pharmaceuticals market segmentation by therapeutic class 2015 Exhibit 18: Drivers and challenges of global OTC pharmaceuticals market Exhibit 19: Global dietary supplements market 2015-2020 ($ billions) Exhibit 20: Global dietary supplements market by geography 2015 Exhibit 21: Segmentation of global dietary supplements market by product type Exhibit 22: Global dietary supplements market by product type 2015 Exhibit 23: Drivers and challenges of global dietary supplements market Exhibit 24: Segmentation of global consumer healthcare market by geography 2015 Exhibit 25: Global consumer healthcare market revenue by geography 2015-2020 ($ billions) Exhibit 26: Global consumer healthcare market revenue by geography 2015-2020 Exhibit 27: Consumer healthcare market in Americas 2015-2020 ($ billions) Exhibit 28: Consumer healthcare market in APAC 2015-2020 ($ billions) Exhibit 29: Consumer healthcare market in EMEA 2015-2020 ($ billions) Exhibit 30: Key leading countries in global consumer healthcare market Exhibit 31: Drivers and challenges Exhibit 32: Drivers and challenges Exhibit 33: Drivers and challenges Exhibit 34: Impact of drivers Exhibit 35: Impact of drivers and challenges Exhibit 36: Global internet penetration rate 2015 Exhibit 37: Johnson & Johnson: Business segmentation by revenue 2014 Exhibit 38: Johnson & Johnson: YoY growth rate and revenue of consumer healthcare segment 2012-2014 ($ billions) Exhibit 39: Johnson & Johnson: Consumer healthcare product categories by revenue 2014 Exhibit 40: Johnson & Johnson: YOY growth rate and revenue of OTC products 2012-2014 ($ billions) Exhibit 41: Johnson & Johnson: YoY growth rate and revenue of skin care products 2012-2014 ($ billions) Exhibit 42: Johnson & Johnson: YoY growth rate and revenue of baby care products 2012-2014 ($ billions) Exhibit 43: Johnson & Johnson: YoY growth rate and revenue of oral care category 2012-2014 ($ billions) Exhibit 44: Johnson & Johnson: YoY growth rate and revenue of wound care/other products 2012-2014 ($ billions) Exhibit 45: Johnson & Johnson: YoY growth rate and revenue of women's health products 2012-2014 ($ billions) Exhibit 46: Johnson & Johnson: Geographical segmentation by consumer healthcare revenue 2014 Exhibit 47: Johnson & Johnson: SWOT analysis Exhibit 48: Bayer HealthCare: Business segmentation by revenue 2014 Exhibit 49: Bayer HealthCare: Consumer health segmentation by revenue 2014 Exhibit 50: Bayer HealthCare: Geographic segmentation of consumer healthcare segment 2014 Exhibit 51: Bayer HealthCare: YoY growth rate and revenue of Contour 2012-2014 ($ millions) Exhibit 52: Bayer HealthCare: YoY growth rate and revenue of Advantage 2012-2014 ($ millions) Exhibit 53: Bayer HealthCare: YoY growth rate and revenue of Aspirin 2012-2014 ($ millions) Exhibit 54: Bayer HealthCare: YoY growth rate and revenue of Aleve 2012-2014 ($ millions) Exhibit 55: Bayer HealthCare: YoY growth rate and revenue of Bepanthen/Bepanthol 2012-2014 ($ millions) Exhibit 56: Bayer Healthcare: SWOT analysis Exhibit 57: GlaxoSmithKline: Business segmentation by revenue 2014 Exhibit 58: GlaxoSmithKline: YoY growth rate and revenue of consumer healthcare segment 2012-2014 ($ billions) Exhibit 59: GlaxoSmithKline: Segmentation of consumer healthcare categories by revenue 2012-2014 Exhibit 60: GlaxoSmithKline: YoY growth rate and revenue of oral health products 2012-2014 ($ billions) Exhibit 61: GlaxoSmithKline: YoY growth rate and revenue of wellness products 2012-2014 ($ billions) Exhibit 62: GlaxoSmithKline: YoY growth rate and revenue of nutrition products 2012-2014 ($ millions) Exhibit 63: GlaxoSmithKline: YoY growth rate and revenue of skin health category 2012-2014 ($ millions) Exhibit 64: GlaxoSmithKline: Geographical segmentation by consumer health revenue 2014 Exhibit 65: GlaxoSmithKline: SWOT analysis Exhibit 66: Sanofi: Business segmentation by revenue 2014 Exhibit 67: Sanofi: Pharmaceutical segment by revenue 2014 Exhibit 68: Sanofi: Geographical segmentation by consumer healthcare revenue 2014 Exhibit 69: Sanofi: YoY growth rate and revenue of Allegra 2012-2014 ($ millions) Exhibit 70: Sanofi: YoY growth rate and revenue of Doliprane 2012-2014 ($ millions) Exhibit 71: Sanofi: YoY growth rate and revenue of Essentiale 2012-2014 ($ millions) Exhibit 72: Sanofi: YoY growth rate and revenue of Enterogermina 2012-2014 ($ millions) Exhibit 73: Sanofi: YoY revenue comparison of Nasacort 2013 and 2014 ($ millions) Exhibit 74: Sanofi: SWOT Analysis Exhibit 75: Pfizer: Business segmentation by revenue 2014 Exhibit 76: Pfizer: Global vaccines, oncology, and consumer healthcare segment by revenue 2014 Exhibit 77: Pfizer: YoY growth rate and revenue of consumer healthcare category 2012-2014 ($ billions) Exhibit 78: Pfizer: SWOT analysis Exhibit 79: Boehringer Ingelheim: Business segmentation by revenue 2014 Exhibit 80: Boehringer Ingelheim: YoY revenue and growth rate of Buscopan 2012-2014 ($ millions) Exhibit 81: Boehringer Ingelheim: YoY revenue and growth rate of Dulcolax 2012-2014 ($ millions) Exhibit 82: Boehringer Ingelheim: YoY revenue and growth rate of Mucosolvan 2012-2014 ($ millions) Exhibit 83: Boehringer Ingelheim: YoY revenue and growth rate of Pharmaton 2012-2014 ($ millions) Exhibit 84: Boehringer Ingelheim: SWOT analysis

Bayer HealthCare, Boehringer Ingelheim, GlaxoSmithKline, Johnson & Johnson, Pfizer, Sanofi, Abbott Laboratories, American Health, Amway, Arena Pharmaceuticals, BASF, BioGaia, Bukwang Pharmaceutica, Chr. Hansen, Danone, DSM, Eisai, EMS, Euradite Consumer Health and Life Care, Friggs, Genomma Lab Internacional, Glanbia, Herbalife, The Himalaya Drug Company, Kellogg, McNeil Consumer Healthcare, Mead Johnson Nutrition, Merck, Mitsubishi Tanabe Pharma, Nestlé, Novartis, Nutrition & Santé, Omega Pharma, Procter & Gamble, Reckitt Benckiser, SAVA Global, Sigma Pharmaceuticals, Sun Pharma, Taisho Pharmaceuticals, Takeda Pharmaceuticals, Teva Pharmaceuticals, Unifarma Global Consumer Healthcare, Vida Laboratories, Yakult Danone India.